These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6382029)

  • 21. Antagonistic effects of systemic interleukin 2 on immune Tcell-mediated graft-versus-leukemia reactivity.
    Schirrmacher V; Müerköster S; Umansky V
    Clin Cancer Res; 1998 Nov; 4(11):2635-45. PubMed ID: 9829726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The novel IMPDH inhibitor VX-497 prolongs skin graft survival and improves graft versus host disease in mice.
    Decker CJ; Heiser AD; Chaturvedi PR; Faust TJ; Ku G; Moseley S; Nimmesgern E
    Drugs Exp Clin Res; 2001; 27(3):89-95. PubMed ID: 11447770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Derivatives of benzo(c)fluorene. XVII. Pharmacokinetics of benfluron in animals].
    Roubal Z; Poláková L; Grimová J; Kakác B; Peterková M; Rejholec V; Sedlmayer P; Janků I
    Cesk Farm; 1985 Oct; 34(8):311-3. PubMed ID: 4064124
    [No Abstract]   [Full Text] [Related]  

  • 24. The local xenogeneic graft-versus-host reaction as a clinical test for immunocompetence of human T lymphocytes.
    Shohat B; Trainin N
    Thymus; 1980 Sep; 2(2):93-105. PubMed ID: 6969478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
    Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of local and systemic GVHR by supernatants from human choriocarcinoma cell lines.
    Krishnan L; Kinsky R; Chaouat G; Talwar GP; Raghupathy R
    Cell Immunol; 1993 Sep; 150(2):376-81. PubMed ID: 8370079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandins and cell-mediated immunity. The role of prostaglandin E1 in the induction of host-versus-graft and graft-versus-host reactions in mice.
    Mertin J; Stackpoole A; Shumway SJ
    Transplantation; 1984 Apr; 37(4):396-402. PubMed ID: 6710595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of the newly-developed Czechoslovak cytostatic, Benfluron, on the morphology of the blood and bone marrow in laboratory rats].
    Berger J; Nĕmec J
    Cas Lek Cesk; 1986 Aug; 125(31):969-73. PubMed ID: 3731239
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of interferon on cell-mediated immunity.
    De Maeyer E; De Maeyer-Guignard J
    Tex Rep Biol Med; 1977; 35():370-4. PubMed ID: 29358
    [No Abstract]   [Full Text] [Related]  

  • 31. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The flavonoid Kaempferol suppresses the graft-versus-host reaction by inhibiting type 1 cytokine production and CD8+ T cell engraftment.
    Okamoto I; Iwaki K; Koya-Miyata S; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Clin Immunol; 2002 May; 103(2):132-44. PubMed ID: 12027418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of chloroquine diphosphate on the local graft-versus-host reaction and skin graft survival in mice.
    Rybczyńska Z; Kozakiewicz HM; Jamróg-Cendrzak A
    Folia Biol (Krakow); 1978; 26(4):349-53. PubMed ID: 33071
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of 2,7-bis(2-diethylamino)ethoxy)fluoren-9-one dihydrochloride (Tilorone) upon cell-mediated immunity in mice.
    Friedlaender GE; Mosher MB; Mitchell MS
    Cancer Res; 1974 Feb; 34(2):304-7. PubMed ID: 4544018
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of the cysteine derivatives on the cell-mediated immunity.
    Ryzewski J; Kossakowska M; Krzystyniak K
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):913-6. PubMed ID: 749839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromatographic characterization of in vitro metabolites of 5-[2-(N,N-dimethylamino)ethoxy]-7-oxo-7H-benzo[c]fluorene.
    Kvasnicková E; Nobilis M; Hais IM
    J Chromatogr; 1984 Jul; 295(1):201-9. PubMed ID: 6470084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Method for isolation of the immunosuppressive peptide fraction in human blood].
    Lostický C; Cajthamlová H; Soucek J; Bednarík T
    Cesk Farm; 1981 Sep; 30(7):230-2. PubMed ID: 7030493
    [No Abstract]   [Full Text] [Related]  

  • 38. Blocking activity of the serum from semiallogeneic chimaeras produced by means of cyclophosphamide.
    Nagurskaya EV; Chernyakhovskaya IJ; Fontalin LN
    Folia Biol (Praha); 1984; 30(4):209-20. PubMed ID: 6383881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. Regulation of cytokines and CD8+ lymphoid engraftment.
    Fowler DH; Kurasawa K; Husebekk A; Cohen PA; Gress RE
    J Immunol; 1994 Feb; 152(3):1004-13. PubMed ID: 7905495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levamisole and graft-versus-host reaction (GvHR) in rats.
    Sikorska H
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):565-76. PubMed ID: 7458594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.